Neonatal-Diagnostik-Unternehmen InfanDx schließt Serie A Finanzierung ab
InfanDx AG (Köln, Deutschland), ein privat finanziertes Diagnostikunternehmen, das neuartige diagnostische Verfahren fü…
InfanDx AG (Köln, Deutschland), ein privat finanziertes Diagnostikunternehmen, das neuartige diagnostische Verfahren fü…
Lonza reports restated 2020 financials for sales, EBIT, EBITDA and CORE EBITDA Lonza now provides 2020 financials in the…
Lonza delivers on guidance1 with CHF 4.5 billion sales, 12.0%2 sales growth, and CHF 1.4 billion CORE EBITDA, resulting…
Pierre-Alain Ruffieux today commences his role as Chief Executive Officer, following his appointment in June 2020. Alber…
Lonza provides the details of its new structural design, culture and external reporting 2023 Group guidance: double-digi…
Strong operational performance maintained during COVID-19; sites remained open and protection of employees continues to…
Due to COVID-19, Lonza provides the following update outside of the regular reporting cycle: Group net sales reache…
Lonza Group delivers on guidance1 with 6.8% sales growth, resulting in CHF 5.9bn sales, and CHF 1.6bn CORE EBITDA, r…
Double-digit sales growth delivered by Pharma Biotech & Nutrition (LPBN) segment H1 headwinds in Specialty Ingredients (…
As a pre-information for the reporting of the Half-Year Results 2019 on 24 July 2019, Lonza today is providing restated…